Yellow fever is a serious disease spread by Aedes aegypti mosquitoes, which also transmit dengue and Zika viruses. Mosquitoes normally breed in tropical rainforests, semi-humid environments, and humid environments, as well as around bodies of still water. Increased contact between humans and infected mosquitoes, specifically in areas where people haven’t been vaccinated for yellow fever, can create small-scale epidemics. The WHO estimates that 50% of people who develop severe symptoms of this condition die. Older adults and those with compromised immune systems are at a risk for serious complications. The common symptoms of yellow fever include headache, nausea, fever, and vomiting. In severe cases, yellow fever affects some key organs such as the heart, kidney, and liver.
Market Dynamics
The increasing research and studies on yellow fever are expected to drive the global yellow fever treatment market growth during the forecast period. For instance, the Epicentre study, in collaboration with the Kenya Medical Research Institute, Institut Pasteur de Dakar, and WHO, carried out a randomized, double-blind trial in Mbarara, Kenya, Kilifi, and Uganda. The trial was carried out between November 6, 2017 and February 21, 2018. During this period, researchers administered one-fifth of a standard dose of yellow fever vaccine to about 960 adults between the ages of 18 and 59 years. In this study, it was found that giving people just one-fifth of a yellow fever vaccine was as effective as giving them a full dose. This means that more lives can be saved during outbreaks of the deadly disease. This study was led by Epicentre, the research arm of Médecins Sans Frontières / Doctors without Borders (MSF).
Key features of the study:
- This report provides an in-depth analysis of the global yellow fever treatment market, market size (US$ Mn), and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global yellow fever treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Sanofi Pasteur SA, Janssen, Pfizer Inc., BIOCRYST PHARMACEUTICALS, INC., Tychan Pte. Ltd., Johnson & Johnson Services, Inc., Takeda Pharmaceutical Company Limited, Bayer AG, GlaxoSmithKline plc, Bio-Manguinhos, Institut Pasteur de Dakar, and FSUE Chumakov
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global yellow fever treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global yellow fever treatment market
Detailed Segmentation:
- Global Yellow Fever Treatment Market, By Transmission Type:
- Sylvatic Yellow Fever
- Intermediate Yellow Fever
- Urban Yellow Fever
- Global Yellow Fever Treatment Market, By Treatment Type:
- Vaccines
- Medications
- Others
- Global Yellow Fever Treatment Market, By Application:
- Hospitals
- Clinics
- Community Health Centres
- Others
- Global Yellow Fever Treatment Market, By Region:
- North America
- Transmission Type
- Sylvatic Yellow Fever
- Intermediate Yellow Fever
- Urban Yellow Fever
- Treatment Type
- Vaccines
- Medications
- Others
- Application
- Hospitals
- Clinics
- Community Health Centers
- Others
- By Country
- Latin America
- Transmission Type
- Sylvatic Yellow Fever
- Intermediate Yellow Fever
- Urban Yellow Fever
- Treatment Type
- Vaccines
- Medications
- Others
- Application
- Hospitals
- Clinics
- Community Health Centers
- Others
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Transmission Type
- Sylvatic Yellow Fever
- Intermediate Yellow Fever
- Urban Yellow Fever
- Treatment Type
- Vaccines
- Medications
- Others
- Application
- Hospitals
- Clinics
- Community Health Centers
- Others
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Transmission Type
- Sylvatic Yellow Fever
- Intermediate Yellow Fever
- Urban Yellow Fever
- Treatment Type
- Vaccines
- Medications
- Others
- Application
- Hospitals
- Clinics
- Community Health Centers
- Others
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Transmission Type
- Sylvatic Yellow Fever
- Intermediate Yellow Fever
- Urban Yellow Fever
- Treatment Type
- Vaccines
- Medications
- Others
- Application
- Hospitals
- Clinics
- Community Health Centers
- Others
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- Transmission Type
- Sylvatic Yellow Fever
- Intermediate Yellow Fever
- Urban Yellow Fever
- Treatment Type
- Vaccines
- Medications
- Others
- Application
- Hospitals
- Clinics
- Community Health Centers
- Others
- By Country/Region
- South Africa
- Central Africa
- North Africa
- Company Profiles
-
- Sanofi Pasteur SA*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Janssen
- Pfizer Inc.
- BIOCRYST PHARMACEUTICALS, INC.
- Tychan Pte. Ltd.
- Johnson & Johnson Services, Inc.
- Takeda Pharmaceutical Company Limited
- Bayer AG
- GlaxoSmithKline plc
- Bio-Manguinhos
- Institut Pasteur de Dakar
- FSUE Chumakov
“*” marked represents similar segmentation in other categories in the respective section.
